Jula Inrig - 22 Jun 2026 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Reporting relationship: CHIEF MEDICAL OFFICER
Issuer ticker: TVTX
Reported as of: 22 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Jun 2026, 16:37:11 UTC
Prior SEC filing: 06 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Elizabeth E. Reed, Attorney-in-Fact

Key filing fact

Jula Inrig filed Form 4 for Travere Therapeutics, Inc. (TVTX) on 22 Jun 2026.

Key facts

This page summarizes Jula Inrig's Form 4 filing for Travere Therapeutics, Inc. (TVTX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Jun 2026, 16:37.

Change

Previous filing in this sequence was filed on 06 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001902368 Primary reporting owner

Inrig Jula

Relationship: CHIEF MEDICAL OFFICER
Address: C/O TRAVERE THERAPEUTICS, INC., 3611 VALLEY CENTRE DRIVE, SUITE 300, SAN DIEGO
Signature: /s/ Elizabeth E. Reed, Attorney-in-Fact
Signature date: 22 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TVTX transaction

Common Stock

Gift

Transaction value
Shares: -468
Change %: -0.41%
Price: $0.000000^*
Shares after: 112,770
Date: 22 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction represents a bona fide gift of 468 shares of common stock to a donor-advised fund. The reporting person authorized the gift on June 16, 2026, and the transfer occurred on June 22, 2026.